Danaher Corporation $DHR Shares Purchased by Rockland Trust Co.

Rockland Trust Co. boosted its stake in shares of Danaher Corporation (NYSE:DHR) by 1,318.0% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 94,026 shares of the conglomerate’s stock after purchasing an additional 87,395 shares during the period. Rockland Trust Co.’s holdings in Danaher were worth $20,831,000 at the end of the most recent reporting period.

Several other institutional investors also recently made changes to their positions in the stock. First Command Advisory Services Inc. increased its holdings in shares of Danaher by 4.4% during the 4th quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock worth $253,000 after buying an additional 47 shares during the last quarter. Studio Investment Management LLC grew its position in Danaher by 3.3% during the second quarter. Studio Investment Management LLC now owns 1,581 shares of the conglomerate’s stock valued at $302,000 after acquiring an additional 51 shares during the period. Clal Insurance Enterprises Holdings Ltd grew its position in Danaher by 71.6% during the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after acquiring an additional 53 shares during the period. JDH Wealth Management LLC increased its stake in Danaher by 4.5% during the first quarter. JDH Wealth Management LLC now owns 1,264 shares of the conglomerate’s stock worth $240,000 after acquiring an additional 55 shares during the last quarter. Finally, OneAscent Financial Services LLC increased its stake in Danaher by 5.5% during the fourth quarter. OneAscent Financial Services LLC now owns 1,069 shares of the conglomerate’s stock worth $245,000 after acquiring an additional 56 shares during the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Stock Up 2.1%

Shares of DHR stock traded up $4.54 during trading hours on Monday, reaching $218.59. The company had a trading volume of 723,152 shares, compared to its average volume of 4,454,141. The company has a market capitalization of $153.67 billion, a P/E ratio of 38.80, a price-to-earnings-growth ratio of 2.67 and a beta of 0.76. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The stock’s fifty day simple moving average is $209.20 and its 200 day simple moving average is $193.70.

Danaher (NYSE:DHR) last released its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. During the same quarter in the prior year, the business earned $0.77 EPS. Danaher’s quarterly revenue was up 5.5% compared to the same quarter last year. As a group, sell-side analysts expect that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be paid a $0.40 dividend. The ex-dividend date is Wednesday, September 30th. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. Danaher’s dividend payout ratio is 28.42%.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the company. Stifel Nicolaus reduced their price objective on Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Wells Fargo & Company dropped their target price on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 22nd. Evercore restated an “outperform” rating and issued a $230.00 price target on shares of Danaher in a report on Monday, July 6th. Royal Bank Of Canada boosted their price objective on shares of Danaher from $215.00 to $250.00 and gave the stock an “outperform” rating in a research note on Monday. Finally, Piper Sandler initiated coverage on shares of Danaher in a research report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price objective for the company. Two analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $234.09.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.